US 7671058
N-(3,4-disubstituted phenyl) salicylamide derivatives
granted A61PA61P1/00A61P1/04
Quick answer
US patent 7671058 (N-(3,4-disubstituted phenyl) salicylamide derivatives) held by Institute of Medicinal Molecular Design, Inc. expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Institute of Medicinal Molecular Design, Inc.
- Grant date
- Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P11/00, A61P11/06